Medication info
Candesartan Tablets 16 mg (Candesartan Cilexetil)

Candesartan Tablets 16 mg (Candesartan Cilexetil)

Prescription medicationTabletOral
Ingredient · strength
Candesartan Cilexetil›16mg / 1 tablet
Manufacturer / importer
Donggu Bio Pharmaceutical Co., Ltd.
Appearance
Light yellow-pink round tablets with both sides convex
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201905791 · Approved 2019.08.14 · Insurance code 657307780

Summary

Main use
Treatment of essential hypertension and heart failure with reduced left ventricular systolic function
Who takes it
Adults · Children
Adult dose
This medicine should be taken at the same time each day, regardless of meals. 1. Essential hypertension 1) Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is still not controlled at this dose, another treatment should be considered. The maximum effect is reached within 4 weeks after starting treatment. 2) Elderly patients: No adjustment of the initial dose is necessary. 3) Patients with intravascular volume depletion: For patients at high risk of hypotension, such as those with volume depletion, administer an initial dose of 4 mg with careful monitoring. 4) Patients with renal impairment: The initial dose for patients with renal impairment, including those undergoing hemodialysis, is 4 mg; adjust the dose according to the patient's response. Experience with use in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min) is limited. 5) Patients with hepatic impairment: The initial dose for patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience with use in patients with severe hepatic impairment. 2. Heart failure 1) Adults: An initial dose of 4 mg once daily is recommended. The dose may be doubled at intervals of at least 2 weeks, taking the patient's tolerability into consideration, up to a maximum of 32 mg once daily. 2) Elderly patients, patients with intravascular volume depletion, patients with renal impairment, and patients with mild to moderate hepatic impairment: No adjustment of the initial dose is necessary.
Child dose
1. Essential hypertension: The safety and efficacy in adolescents and children aged 18 years or younger have not been established. 2. Heart failure: The safety and efficacy in adolescents and children aged 18 years or younger have not been established.

Ingredients

Manufacturer
Donggu Bio Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and heart failure with reduced left ventricular systolic function

  • Essential hypertension
  • heart failure
  • left ventricular systolic dysfunction
  • decreased left ventricular ejection fraction
View approved original text

This medication is used for controlling blood pressure in patients with essential hypertension. It is also suitable for severe heart failure patients whose left ventricular function is impaired and who need additional treatment with ACE inhibitors or have difficulty using ACE inhibitors. This efficacy helps stabilize blood pressure and improve heart function.

How to take

Adult dose

This medicine should be taken at the same time each day, regardless of meals. 1. Essential hypertension 1) Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is still not controlled at this dose, another treatment should be considered. The maximum effect is reached within 4 weeks after starting treatment. 2) Elderly patients: No adjustment of the initial dose is necessary. 3) Patients with intravascular volume depletion: For patients at high risk of hypotension, such as those with volume depletion, administer an initial dose of 4 mg with careful monitoring. 4) Patients with renal impairment: The initial dose for patients with renal impairment, including those undergoing hemodialysis, is 4 mg; adjust the dose according to the patient's response. Experience with use in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min) is limited. 5) Patients with hepatic impairment: The initial dose for patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience with use in patients with severe hepatic impairment. 2. Heart failure 1) Adults: An initial dose of 4 mg once daily is recommended. The dose may be doubled at intervals of at least 2 weeks, taking the patient's tolerability into consideration, up to a maximum of 32 mg once daily. 2) Elderly patients, patients with intravascular volume depletion, patients with renal impairment, and patients with mild to moderate hepatic impairment: No adjustment of the initial dose is necessary.

Child dose

1. Essential hypertension: The safety and efficacy in adolescents and children aged 18 years or younger have not been established. 2. Heart failure: The safety and efficacy in adolescents and children aged 18 years or younger have not been established.

Precautions

This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately if pregnancy is confirmed. This drug should not be used in patients with certain allergic reactions, severe liver disease or cholestasis, hereditary angioedema, or specific genetic disorders. Special caution is required for elderly patients, those with poor kidney function, patients with hyperkalemia, and those with heart valve diseases when using this medication. During treatment, side effects such as dizziness, back pain, and respiratory infections may occur, and in some patients, serious blood abnormalities or liver function abnormalities may develop, so if any abnormal symptoms appear, medical consultation should be sought immediately. Due to the risk of decreased kidney function, hyperkalemia, hypotension, etc., regular blood tests and kidney function tests are necessary, and particular caution is required for heart failure patients or kidney transplant patients. The blood pressure-lowering effect may increase when taking this medication in combination with other antihypertensive agents or certain diuretics, so it is essential to inform the healthcare provider about any other medications being taken. Pregnant or breastfeeding women should avoid using this medication; if unavoidable, breastfeeding should be stopped. Safety and effectiveness have not been established in children and adolescents, so use is not recommended in this age group. In case of overdose, symptoms such as hypotension and dizziness may occur, and emergency treatment should be sought immediately, as this medication is not removed by dialysis. This medication should be kept out of the reach of children, and transferring it to another container should be avoided as it is detrimental to quality preservation. Caution should be exercised when driving or operating machinery, as dizziness may occur.

Side effects

  • Dizziness
  • back pain
  • respiratory infection
  • upper respiratory tract infection
  • pharyngitis
  • rhinitis
  • asthenia
  • fever
  • sensory disturbances
  • dyspepsia
Show 66 more
  • gastroenteritis
  • tachycardia
  • palpitations
  • increased creatine kinase
  • hyperglycemia
  • hypertriglyceridemia
  • hyperuricemia
  • myalgia
  • epistaxis
  • anxiety
  • depression
  • drowsiness
  • dyspnea
  • rash
  • increased sweating
  • hematuria
  • hypotension
  • hyperkalemia
  • renal function impairment
  • increased creatinine
  • increased urea
  • headache
  • bronchitis
  • cough
  • sinusitis
  • nausea
  • abdominal pain
  • diarrhea
  • vomiting
  • arthralgia
  • proteinuria
  • leukopenia
  • neutropenia
  • agranulocytosis
  • hyponatremia
  • hypoglycemia
  • intestinal vascular edema
  • increased liver enzyme levels
  • hepatitis
  • elevated AST
  • elevated ALT
  • elevated γ-GTP
  • jaundice
  • urticaria
  • itching
  • angioedema
  • rhabdomyolysis
  • acute renal failure
  • interstitial pneumonia
  • shock
  • syncope
  • loss of consciousness
  • paralysis
  • hypertonia
  • facial flushing
  • weight gain
  • facial edema
  • thirst
  • sleep disturbances
  • reduced libido
  • forgetfulness
  • loss of appetite
  • increased appetite
  • tinnitus
  • taste disturbance
  • erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. Additionally, it is best stored at room temperature between 1 to 30 degrees Celsius. This helps maintain the medication’s effectiveness for a longer period.

Appearance and packaging

Appearance

Light yellow-pink round tablets with both sides convex

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.